Skip to Content


In the US, Adefovir (adefovir systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat Hepatitis B.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiviral agent

Antiviral agent: Treatment of hepatitis B

Nucleotide reverse transcriptase inhibitor (NtRTI)

Chemical Name

[[2-(6-Amino-9H-purin-9-yl)etoxy]metyl]phosphonic acid (WHO)

Foreign Names

  • Adefovirum (Latin)
  • Adefovir (German)
  • Adéfovir (French)
  • Adefovir (Spanish)

Generic Names

  • Adefovir (OS: BAN, USAN)
  • GS 0393 (IS)
  • Adefovir Dipivoxil (OS: USAN, BANM)
  • Adefovir Pivoxil (OS: JAN)
  • Bis (pom) PMEA (IS)
  • GS 0840 (IS: GileadSciences)
  • Piv2 PMEA (IS)
  • Preveon (IS: Bristol-Myers)

Brand Names

  • Fodavir
    Eva, Egypt
  • Hepsera
    Gilead, United States; GlaxoSmithKline, Egypt
  • A Di Xian
    The United Laboratories Ltd, China
  • A Gan Ding
    Fujian Guangsheng Tang, China
  • Adefovir Stada
    Stada-VN JV, Vietnam
  • Adepact
    Hyundai, South Korea
  • Adepsera
    Green Cross, South Korea
  • Adfovir
    Sun Pharma, Myanmar; Sun Pharmaceutical Industries Ltd, Malaysia
  • Afoliva
    Samjin, South Korea
  • Ailuwei
    Changzheng-Xinkai, China
  • Antiva
    Square, Bangladesh
  • Biovir
    Ivax, Argentina
  • Dai Ding
    Tianjin Institute of Pharmaceutical Research Pharmaceutical, China
  • Dinghe
    Lukang, China
  • Everhepa
    Chong Kun Dang, South Korea
  • Hepcure
    CJ Cheiljedang, South Korea
  • Hepsera
    Gilead, Australia; Gilead, Belgium; Gilead, Canada; Gilead, Switzerland; Gilead, Czech Republic; Gilead, Germany; Gilead, Denmark; Gilead, Spain; Gilead, France; Gilead, Greece; Gilead, Hungary; Gilead, Ireland; Gilead, Iceland; Gilead, Italy; Gilead, Lithuania; Gilead, Netherlands; Gilead, Norway; Gilead, New Zealand; Gilead, Portugal; Gilead, Romania; Gilead, Sweden; Gilead, Slovenia; Gilead, Slovakia; Gilead, Turkey; GlaxoSmithKline, Argentina; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Colombia; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Japan; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Philippines; GlaxoSmithKline, Singapore; GlaxoSmithKline, Thailand; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Venezuela; GlaxoSmithKline, Vietnam; Patheon, Israel
  • Hepses
    Myungmoon, South Korea
  • Hepsevir
    Dong-A, South Korea
  • Infovir
    Incepta, Bangladesh; Incepta, Myanmar
  • Jiule
    Fovir Pharm, China
  • Lifuzhi
    Jiangsu TianShiLi BeiTe Pharmaceutical Co., Ltd., China
  • Ming Zheng
    Chia Tai Tianqing, China
  • Xinfunuo
    SL Pharm, China
  • Yilaifen
    Qilu, China
  • Youheding
    YSY Pharmaceutical, China
  • Yubao
    Xinghu Biochem Pharm, China

International Drug Name Search


BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.